tradingkey.logo
Search
Markets
News
Analysis
Tools
Stock Screener
Learn
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Johnson & Johnson

JNJ
Add to Watchlist
259.290USD
-3.750-1.43%
Close 07/06, 16:00（ET）Quotes delayed by 15 min
624.00BMarket Cap
29.67P/E TTM

Johnson & Johnson

259.290
-3.750-1.43%
Overview
Financials
Discussions
Analysis
Company
ProfileRevenueShareholdersCorporate

Overview

Financials

Discussions

Analysis

Company

ProfileRevenueShareholdersCorporate

More Details of Johnson & Johnson Company

Johnson & Johnson is an American multinational corporation specializing in pharmaceuticals, biotechnology, and medical technologies, headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange (NYSE:JNJ). Its common stock is part of the Dow Jones Industrial Average, and the company is ranked No. 42 on the 2024 Fortune 500 list of the largest corporations in the United States. In 2024, it was ranked 45th on the Forbes Global 2000 list. Johnson & Johnson employs approximately 138,000 individuals globally, led by its current chairman and CEO, Joaquin Duato.

Founded in 1886 by three brothers—Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson—the company initially focused on selling ready-to-use sterile surgical dressings. In 2023, the firm spun off its consumer healthcare business segment into a new publicly traded entity, Kenvue, allowing it to concentrate solely on the development and manufacturing of pharmaceutical prescription drugs and medical device technologies.

Johnson & Johnson is recognized as one of the most valuable companies worldwide and is one of only two U.S.-based corporations possessing a prime credit rating of AAA.

Johnson & Johnson Info

Ticker SymbolJNJ
Company nameJohnson & Johnson
IPO dateOct 31, 2080
CEODuato (Joaquin Boix)
Number of employees138100
Security typeOrdinary Share
Fiscal year-endOct 31
AddressOne Johnson & Johnson Plaza
CityNEW BRUNSWICK
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code08933
Phone17325242455
Websitehttps://www.jnj.com/
Ticker SymbolJNJ
IPO dateOct 31, 2080
CEODuato (Joaquin Boix)

Company Executives of Johnson & Johnson

Name
Name/Position
Position
Shareholding
Change
Mr. Joaquin Boix Duato
Mr. Joaquin Boix Duato
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
356.30K
+22.28%
Ms. Jennifer L. Taubert
Ms. Jennifer L. Taubert
Executive Vice President, Worldwide Chairman, Innovative Medicine
Executive Vice President, Worldwide Chairman, Innovative Medicine
194.45K
+8.45%
Ms. Kathryn E. Wengel
Ms. Kathryn E. Wengel
Executive Vice President, Chief Technology Officer and Risk Officer
Executive Vice President, Chief Technology Officer and Risk Officer
114.63K
--
Mr. Joseph J. Wolk
Mr. Joseph J. Wolk
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
85.01K
+0.07%
Prof. Dr. John C. Reed, M.D., Ph.D.
Prof. Dr. John C. Reed, M.D., Ph.D.
Executive Vice President - Innovative Medicine, Research and Development
Executive Vice President - Innovative Medicine, Research and Development
24.91K
+57.22%
Ms. Elizabeth (Liz) Forminard
Ms. Elizabeth (Liz) Forminard
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
23.57K
+45.46%
Ms. Vanessa Broadhurst
Ms. Vanessa Broadhurst
Executive Vice President - Global Corporate Affairs
Executive Vice President - Global Corporate Affairs
23.00K
-2.57%
Ms. Kristen Mulholland
Ms. Kristen Mulholland
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
19.83K
+28.80%
Mr. Hubert Joly
Mr. Hubert Joly
Independent Director
Independent Director
5.00K
--
Ms. Marillyn A. Hewson
Ms. Marillyn A. Hewson
Lead Independent Director
Lead Independent Director
3.00K
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Joaquin Boix Duato
Mr. Joaquin Boix Duato
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
356.30K
+22.28%
Ms. Jennifer L. Taubert
Ms. Jennifer L. Taubert
Executive Vice President, Worldwide Chairman, Innovative Medicine
Executive Vice President, Worldwide Chairman, Innovative Medicine
194.45K
+8.45%
Ms. Kathryn E. Wengel
Ms. Kathryn E. Wengel
Executive Vice President, Chief Technology Officer and Risk Officer
Executive Vice President, Chief Technology Officer and Risk Officer
114.63K
--
Mr. Joseph J. Wolk
Mr. Joseph J. Wolk
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
85.01K
+0.07%
Prof. Dr. John C. Reed, M.D., Ph.D.
Prof. Dr. John C. Reed, M.D., Ph.D.
Executive Vice President - Innovative Medicine, Research and Development
Executive Vice President - Innovative Medicine, Research and Development
24.91K
+57.22%
Ms. Elizabeth (Liz) Forminard
Ms. Elizabeth (Liz) Forminard
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
23.57K
+45.46%

FAQs

Who are the top five shareholders of Johnson & Johnson?

The top five shareholders of Johnson & Johnson are: Mr. Joaquin Boix Duato

How many institutions hold shares of Johnson & Johnson (JNJ)?

As of 2026Q1, 6338 institutions hold shares of Johnson & Johnson, with a combined market value of approximately 1.78B, accounting for 73.80% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -65473493.00.

What is the biggest source of revenue for Johnson & Johnson?

In 2026Q1, the Oncology-DARZALEX business generated the highest revenue for Johnson & Johnson, amounting to 14.35B and accounting for 15.24% of total revenue.